These changes were commonly regarded as indicators of active atherogenetic process and risk for cardiovascular disease: elevated levels of total cholesterol, LDL-C, apo-B, apo-B/apo A1 ratio, TAG, and decreased levels of HDL cholesterol and Apo-A (Table 2). The gene discussed is APOB; the disease is cardiovascular disorder.